24th Congress of the European Hematology Association
Recent research shows that a biomarker-driven approach to treating multiple myeloma patients with venetoclax may be best ...
Check out the latest news from the 24th Congress of the European Hematology Association. ...
Research presented at the 24th Congress of the European Hematology Association (EHA) found that potent inhibitors of ...
Research presented at the European Hematology Association 24th Congress found that the addition of daratumumab to ...
European Hematology Association 24th Congress found that voxelotor significantly increased hemoglobin levels and reduced ...
Research presented last week at the 24th Congress of European Hematology Association (EHA) in Amsterdam found gene ...
Research presented by Dr. Kirsten Fischer at the 24th Congress of European Hematology Association (EHA) in Amsterdam on ...
A new study presented by Dr. Ekaterina Chelysheva at the 24th Congress of European Hematology Association (EHA) in ...
Advertisement
Advertisement
